Explorer les evidences

81 %Among 16 HIV seroconverters in the POWER study, 13 (81%) either did not have PrEP dispensed in the study interval prior to seroconversion or had TFV-DP levels indicating <4 doses per week in the prior 6 weeks.

KenyaVIH/sidapublié 2022Journal of the International AIDS SocietyPubMeddocument de 12 observations

3,57 odds_ratioParticipants who had previously used fingerprint biometric systems for identification had an odds ratio of 3.57 for accepting fingerprint technology in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublié 2021Journal of medical Internet researchPubMeddocument de 11 observations

37 %Among 187 participants with second-line viral failure, major PI resistance prevalence was 37%.

KenyaVIH/sidaobservé 2011 to 2021publié 2025Journal of the International AIDS SocietyPubMeddocument de 15 observations

95,4 %Among 154 children with nodding syndrome, 147 (95.4%) had been exposed to Onchocerca volvulus.

Kenyanodding syndromepublié 2021Epilepsia openeurope_pmcdocument de 5 observations

66 %Two-thirds (66%) of Chlamydia trachomatis and/or Neisseria gonorrhoeae cases were asymptomatic among pregnant Kenyan women.

KenyaChlamydia trachomatispublié 2024Sexually transmitted diseasesPubMeddocument de 7 observations

42 %Leukocytosis was present in 42% of malaria-infected children with HbAS genotype.

Kenyapaludismepublié 2021BMC infectious diseasesPubMeddocument de 13 observations

5,2 %Women in Kenya have an HIV prevalence rate of 5.2%.

KenyaVIH/sidapublié 2025AIDS research and therapyPubMeddocument de 6 observations

At 1 year of age, HEU infants had higher language scores and comparable scores in fine motor, gross motor and social scores compared to HUU infants using the Malawi developmental assessment tool.

KenyaVIH/sidapublié 2024BMJ openPubMeddocument de 4 observations

5,16 ORHypoglycaemia was associated with severe metabolic acidosis with an odds ratio of 5.16.

Kenyasevere metabolic acidosispublié 2021Malaria journalPubMeddocument de 14 observations

888 recordsOf the 1,154 medical records abstracted, 888 (76%) were from adolescent girls and young women seeking HIV treatment.

KenyaVIH/sidapublié 2023Frontiers in public healthPubMeddocument de 9 observations

4 %Among the 1178 clients reached for follow-up, 4% (42/1178) tested HIV-positive and reported ART referral.

KenyaVIH/sidaobservé March to June 2022publié 2025BMC health services researchPubMeddocument de 13 observations

57 %After two, four and eight treatment rounds, the prevalence of CFA positivity was 57%, compared with pre-treatment.

Kenyacirculating filarial antigen (CFA) · Wuchereria bancrofti infectionpublié 2005Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 7 observations

85 %At 48 weeks, viral suppression was 85% in the intervention group and 86% in the control group.

KenyaVIH/sidaobservé 48 weekspublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations

17,7 %Only 17.7% of HIV-positive adolescents had electricity at home.

KenyaVIH/sidapublié 2020Reproductive healthPubMeddocument de 8 observations

28 daysAntibody-neutralising potencies peaked at day 28 after PCR testing.

KenyaCOVID-19publié 2023Wellcome open researcheurope_pmcdocument de 4 observations

0,22 odds_ratioWearing hats was protective against ocular surface squamous neoplasia (OSSN) with an odds ratio of 0.22.

Kenyaocular surface squamous neoplasia (OSSN)publié 2016Tropical medicine & international health : TM & IHeurope_pmcdocument de 10 observations

29 %Among African adolescent girls and young women enrolled in the POWER study, 29% had chlamydia.

Kenyachlamydiapublié 2022Journal of the International AIDS SocietyPubMeddocument de 12 observations

1,5 %Cumulative mortality incidence among children and adolescents initiating antiretroviral therapy in central Kenya was 1.5% at 36 months.

KenyaVIH/sidapublié 2022AIDS research and human retrovirusesPubMeddocument de 18 observations

627 individualsThe potential number of new HIV diagnoses through hotspot-based rapid testing in Mombasa, Kenya was 627.

KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 11 observations

54 %Within 1 month of diagnosis, 54% of 30 HIV-positive children had started antiretroviral treatment.

KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 7 observations

9 000 casesOver the period 2008–2012, almost 9,000 new cancer cases were registered in older adults in four population-based cancer registries in Kenya (Nairobi), South Africa (Eastern Cape Province), Uganda (Kyadondo county), and Zimbabwe (Harare blacks).

Kenyacancer (non précisé)observé 2008-2012publié 2019International journal of cancereurope_pmcdocument de 6 observationsDOI 10.1002/ijc.31880

293 casesA total of 293 HPV-positive women living with HIV underwent thermal ablation in the study period.

Kenyainfection à HPVobservé August 2019 to February 2020publié 2020JCO global oncologyPubMeddocument de 14 observations

20 %Each additional year of ART use reduced the likelihood of persistent detection of A9 HR-HPV by 20% among Kenyan women living with HIV.

KenyaA9 HR-HPV · VIH/sidapublié 2021International journal of STD & AIDSPubMeddocument de 5 observations

40,1 %Relative to PET-PCR, expert microscopy had a sensitivity of 40.1% (95% confidence interval [CI], 32.7%-47.9%).

Kenyapaludismepublié 2022The Journal of infectious diseasesPubMeddocument de 13 observations

38,6 %During periods of self-reported HIV risk, the difference in time covered by PrEP/PEP between the dynamic choice prevention and standard-of-care arms was 38.6%.

KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 18 observations